Colgate-Palmolive (NYSE:CL) Shares Sold by Stratos Wealth Partners LTD.

Stratos Wealth Partners LTD. lowered its position in Colgate-Palmolive (NYSE:CL - Free Report) by 17.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 17,433 shares of the company's stock after selling 3,700 shares during the period. Stratos Wealth Partners LTD.'s holdings in Colgate-Palmolive were worth $1,585,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive during the 4th quarter worth approximately $32,000. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $42,000. Synergy Asset Management LLC purchased a new stake in Colgate-Palmolive during the 4th quarter worth approximately $49,000. Capital Performance Advisors LLP purchased a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $53,000. Finally, Prospera Private Wealth LLC purchased a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $64,000. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Down 0.7 %

Shares of CL traded down $0.62 during mid-day trading on Wednesday, reaching $86.75. The stock had a trading volume of 3,411,852 shares, compared to its average volume of 5,075,059. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. Colgate-Palmolive has a 52-week low of $82.76 and a 52-week high of $109.30. The business's fifty day moving average is $90.00 and its 200 day moving average is $96.61. The firm has a market cap of $70.88 billion, a price-to-earnings ratio of 24.64, a P/E/G ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the company earned $0.87 earnings per share. On average, sell-side analysts predict that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.31%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio is currently 56.82%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Royal Bank of Canada reissued a "sector perform" rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Raymond James restated an "outperform" rating and set a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Piper Sandler decreased their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research note on Monday, January 6th. UBS Group decreased their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Finally, Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.